Failed drug discovery in psychiatry: time for human genome-guided solutions

Trends in Cognitive Sciences
Andreas Papassotiropoulos, Dominique J-F de Quervain

Abstract

Our knowledge about the molecular and neural mechanisms of emotional and cognitive processes has increased exponentially in the past decades. Unfortunately, there has been no translation of this knowledge into the development of novel and improved pharmacological treatments for psychiatric disorders. We comment on some of the reasons for failed drug discovery in psychiatry, particularly on the use of ill-suited disease models and on the use of diagnostic constructs unrelated to the underlying biological mechanisms. Furthermore, we argue that the use of human genetic findings together with biologically informed phenotypes and advanced data-mining methodology will catalyze the identification of promising drug targets and, finally, will lead to improved therapeutic outcomes.

References

Apr 2, 2003·The American Journal of Psychiatry·Irving I Gottesman, Todd D Gould
Aug 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michael F EganDaniel R Weinberger
Jun 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Joseph H CallicottDaniel R Weinberger
Dec 7, 2007·Archives of General Psychiatry·Timothea ToulopoulouRobin Murray
May 2, 2009·Science·Christine EsslingerAndreas Meyer-Lindenberg
Jun 23, 2009·American Journal of Human Genetics·Peter HolmansNick Craddock
Jul 3, 2010·The American Journal of Psychiatry·Thomas InselPhilip Wang
Jul 22, 2010·The New England Journal of Medicine·Teri A Manolio
Sep 8, 2010·Archives of General Psychiatry·Kristin L BigosDaniel R Weinberger
Nov 19, 2010·Nature Reviews. Genetics·Kai WangHakon Hakonarson
Mar 8, 2011·Current Opinion in Genetics & Development·Roberta Rasetti, Daniel R Weinberger
Jul 8, 2011·Science Translational Medicine·Francis S Collins
Sep 7, 2011·Current Opinion in Pharmacology·Pierandrea Muglia
Sep 20, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Anders GustavssonUNKNOWN CDBE2010Study Group
Sep 20, 2011·Nature Genetics·UNKNOWN Psychiatric GWAS Consortium Bipolar Disorder Working Group
Dec 14, 2011·Nature·Alison Abbott
Mar 16, 2012·The American Journal of Psychiatry·Evangelia StergiakouliAnita Thapar
Mar 28, 2012·Journal of the American Academy of Child and Adolescent Psychiatry·James C McPartlandFred R Volkmar
Apr 12, 2012·Nature Biotechnology·Philippe SanseauVincent Mooser
Oct 12, 2012·Science Translational Medicine·Steven E Hyman
Oct 12, 2012·Science Translational Medicine·Thomas R Insel
Feb 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Junhee SeokUNKNOWN Inflammation and Host Response to Injury, Large Scale Collaborative Research Program
Apr 6, 2013·Nature Medicine
Jul 4, 2013·The American Journal of Psychiatry·Jim van Os
Jul 23, 2013·Nature Reviews. Drug Discovery·Robert M PlengeDavid Altshuler
Oct 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Andreas PapassotiropoulosDominique J-F de Quervain
Feb 6, 2014·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Daniel R Weinberger, Terry E Goldberg
Sep 1, 2004·Drug Discovery Today. Technologies·Daniel G HealyNicholas W Wood
Jul 25, 2014·Nature·UNKNOWN Schizophrenia Working Group of the Psychiatric Genomics Consortium
Aug 27, 2014·Trends in Genetics : TIG·Michael A MooneyBeth Wilmot
Dec 3, 2014·Neuron·Christian R SchubertPatricio O'Donnell

❮ Previous
Next ❯

Citations

May 17, 2015·Neuroscience and Biobehavioral Reviews·Chong ChenIchiro Kusumi
Apr 26, 2016·Annals of the New York Academy of Sciences·Paul J HarrisonJohn R Geddes
Jun 21, 2016·CNS Neuroscience & Therapeutics·Ji-Yun HuangYing-Mei Lu
Feb 1, 2018·Translational Psychiatry·Virginie FreytagAndreas Papassotiropoulos
Mar 1, 2019·Molecular Psychiatry·Gal Richter-LevinMathias V Schmidt
Oct 28, 2016·Nature Neuroscience·Gerome BreenHoward J Edenberg
Dec 18, 2019·Pharmacological Reviews·Jhana O HendrickxStuart Maudsley
Feb 28, 2017·Frontiers in Psychiatry·Roberto Ciccocioppo
Aug 24, 2016·Revue de synthèse·Luc Faucher, Simon Goyer
Oct 11, 2020·Neuroscience and Biobehavioral Reviews·Christian Grillon, Monique Ernst
Aug 16, 2019·Brain, Behavior and Evolution·Jessica A Bolker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Related Papers

Trends in Pharmacological Sciences
Krzysztof Palczewski
Medizinische Klinik
Otmar D Wiestler, Julia Rautenstrauch
Movement Disorders : Official Journal of the Movement Disorder Society
Ira Shoulson, Anne B Young
© 2022 Meta ULC. All rights reserved